FIELD: medicine.
SUBSTANCE: expression plasmid DNA pOptivec/FSBDD coding the human recombinant blood coagulability factor VIII with deletion of B-domain which is used to transform cells of DG-OV-F8BDD-18 line for producing.
EFFECT: invention provides high secretion level of the human recombinant blood coagulability factor VIII with deletion of B-domain in a serum-free culture medium.
2 cl, 1 dwg, 2 ex
Authors
Dates
2011-09-20—Published
2009-10-23—Filed